KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Invested Capital (2016 - 2025)

Historic Invested Capital for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $6.7 billion.

  • Resmed's Invested Capital rose 1367.4% to $6.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.7 billion, marking a year-over-year increase of 1367.4%. This contributed to the annual value of $6.6 billion for FY2025, which is 1914.81% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Invested Capital is $6.7 billion, which was up 1367.4% from $6.5 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Invested Capital ranged from a high of $6.7 billion in Q4 2025 and a low of $3.4 billion during Q1 2021
  • Its 5-year average for Invested Capital is $5.2 billion, with a median of $5.6 billion in 2023.
  • As far as peak fluctuations go, Resmed's Invested Capital plummeted by 535.65% in 2021, and later surged by 4489.14% in 2022.
  • Resmed's Invested Capital (Quarter) stood at $3.8 billion in 2021, then soared by 44.89% to $5.5 billion in 2022, then increased by 3.07% to $5.7 billion in 2023, then increased by 3.81% to $5.9 billion in 2024, then increased by 13.67% to $6.7 billion in 2025.
  • Its Invested Capital stands at $6.7 billion for Q4 2025, versus $6.5 billion for Q3 2025 and $6.6 billion for Q2 2025.